Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women
Launched by FLORIDA A&M UNIVERSITY · Dec 16, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to encourage Hispanic women to get screened for cervical cancer. They will test an online educational program led by a community health worker, called a promotora, to see if it helps women understand the importance of cervical cancer screening and motivates them to schedule a screening. The study will involve 160 Hispanic women aged 21 to 65 who have not had a cervical cancer screening in the last three years or have never been screened. Participants will be randomly assigned to either the cervical cancer education group or a control group that will receive information about healthy nutrition instead.
To be eligible for this study, women must identify as Hispanic, be between 21 and 65 years old, and not have a history of cervical cancer or a hysterectomy. If you join the study, you can expect to attend a virtual educational session where you will learn about cervical cancer screening and receive resources for where to get screened. The researchers hope to see an increase in cervical cancer screenings among participants six months after the program, along with improvements in their knowledge and confidence about getting screened. This trial is important because it aims to help a group of women who are not getting regular screenings, which can be crucial for early detection and prevention of cervical cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. between the age of 21 and 65 years
- • 2. identify as Hispanic
- • 3. not up-to-date with cervical cancer screening \[never screened or last Pap test ≥ 3 years - based on U.S. Preventive Services Task Force guidelines\]
- • 4. have no history of cervical cancer
- • 5. have not had a hysterectomy.
- Exclusion Criteria:
- • 1. under the age of 21 or over the age of 65 years
- • 2. do not identify as Hispanic
- • 3. up-to-date with cervical cancer screening \[last Pap test \< 3 years - based on U.S. Preventive Services Task Force guidelines\]
- • 4. history of cervical cancer
- • 5. have had a hysterectomy.
About Florida A&M University
Florida A&M University (FAMU) is a distinguished public institution dedicated to advancing education, research, and community service. As a clinical trial sponsor, FAMU harnesses its extensive academic resources and expertise to facilitate innovative research initiatives aimed at addressing pressing health challenges. The university emphasizes interdisciplinary collaboration, ensuring that its clinical trials are grounded in rigorous scientific methodology and ethical standards. FAMU is committed to enhancing health outcomes and contributing to the body of knowledge in medicine and public health through its comprehensive approach to clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tallahassee, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported